首页> 外国专利> System of the inspection mannered null suffering inspection

System of the inspection mannered null suffering inspection

机译:检验制度,进行零痛苦检验

摘要

PROBLEM TO BE SOLVED: To provide an examination method and an examination drug which are useful in diagnosis of rectal cancer and adenoma of the large intestine, and by which a patient suffering from the cancer and a patient having a degree of risk of suffering from the cancer of the large intestine can be detected.;SOLUTION: It has been revealed that a remarkable difference in distribution of isozyme for a sugar chain sulfated enzyme GlcNAc-6-sulfuric acid group transferase is found between non-cancerous tissues of the large intestine, and cancerous tissues and a adenoma tissue of the large intestine, and that the GlcNAc-6-sulfated sugar chain groups within a certain range are detected from the patient's tissues and fecal specimens by applying this difference, so that the rectal cancer and adenoma of the large intestine can be detected specifically. When using an MECA-79 antibody (manufactured by a company) which reacts with a GlcNAc-6-suflated sugar chain generated specifically by an enzyme present in the rectal cancer and adenoma of the large intestine, the examination of cancer and adenoma of the large intestine can be conducted.;COPYRIGHT: (C)2005,JPO&NCIPI
机译:解决的问题:提供一种检查方法和检查药物,其可用于诊断大肠的直肠癌和腺瘤,从而使患有癌症的患者和具有一定程度的患上肝癌的风险的患者受益。解决方案:已经发现,在大肠的非癌组织之间,糖链硫酸化酶GlcNAc-6-硫酸基团转移酶的同工酶分布存在显着差异,并通过应用这种差异从患者的组织和粪便标本中检测出一定范围内的GlcNAc-6硫酸化糖链基团,以及大肠癌组织和腺瘤组织。大肠可以被特异性地检测出来。使用与大肠直肠癌和腺瘤中存在的酶特异产生的GlcNAc-6糖链反应的MECA-79抗体(公司制)时,检查大肠癌和腺瘤可通过肠道进行;版权所有:(C)2005,JPO&NCIPI

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号